You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance

Article metrics

Article menu
XML
Case report
Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance

 

Online download statistics by month:

Online download statistics by month: July 2021 to March 2026

AbstractFullPdf
Jul 2021613613212
Aug 202119519545
Sep 202111811857
Oct 202113213235
Nov 202112912960
Dec 202111912227
Jan 20229911032
Feb 2022606522
Mar 2022707225
Apr 2022495227
May 2022688033
Jun 2022535616
Jul 2022424432
Aug 2022606025
Sep 2022717527
Oct 2022848830
Nov 2022464725
Dec 2022454516
Jan 2023525324
Feb 2023676821
Mar 2023444411
Apr 2023313317
May 2023323317
Jun 2023333314
Jul 2023343617
Aug 2023242416
Sep 2023282818
Oct 2023485219
Nov 2023686920
Dec 2023555714
Jan 2024313212
Feb 2024292915
Mar 2024707073
Apr 2024575839
May 2024646620
Jun 2024464620
Jul 2024596019
Aug 2024424118
Sep 2024323224
Oct 2024555528
Nov 2024515222
Dec 2024676719
Jan 2025585822
Feb 202512512520
Mar 2025677121
Apr 2025868636
May 2025484813
Jun 2025313124
Jul 2025110
Jan 2026100
Mar 2026110
Total359036621399